Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-4-28 , DOI: 10.3851/imp3171
Amanda H Yao ₁ , Cecilia L Moore _{1,

2} , Poh Lian Lim ₃ , Jean-Michel Molina _{4,

5} , Juan Sierra Madero ₆ , Stephen Kerr _{1,

7} , Paddy Wg Mallon ₈ , Sean Emery _{1,

9} , David A Cooper ₁ , Mark A Boyd _{1,

10} ,

Affiliation